Levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in chronic venous leg ulcers -: Correlations to healing status

被引:125
作者
Wallace, HJ [1 ]
Stacey, MC [1 ]
机构
[1] Univ Western Australia, Fremantle Hosp, Dept Surg, Fremantle, WA 6160, Australia
关键词
chronic wounds; inflammation;
D O I
10.1046/j.1523-1747.1998.00113.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This study tested the hypothesis that excessive tumor necrosis factor-alpha (TNF-alpha) levels in chronic venous leg ulcers are associated with impaired healing. TNF-alpha was measured by two enzyme-linked immunosorbent assays and a bioassay (KYM-1D4) in paired wound fluid samples collected during the nonhealing and healing phases from 21 human patients with venous leg ulcers. Soluble TNF receptor levels (p55 and p75) were also measured. The levels of immunoreactive TNF-alpha were significantly higher in wound fluid from nonhealing ulcers than in wound fluid from healing ulcers (p < 0.005), whereas the levels of bioactive TNF-alpha were not. Statistical analysis confirmed that TNF-alpha bioactivity relative to the amount of immunoreactive TNF-alpha was downregulated in wound fluid from nonhealing ulcers compared with healing ulcers. The levels of soluble p55 and p75 receptors in wound fluid showed a significant linear correlation (p < 0.001), suggesting a partially coordinated or common regulatory mechanism for the cleavage of transmembrane TNF receptors in chronic venous ulcers in vivo. Although the levels of soluble p75 receptors were significantly higher in nonhealing wound fluid compared with healing wound fluid (p < 0.025), these levels were theoretically inadequate to substantially neutralize the bioactivity of the accompanying TNF-alpha levels on their own. The bioactivity-accompanying the elevated levels of immunoreactive TNF-alpha in wound fluid from nonhealing ulcers may have been further down-modulated by an additional mechanism. Because healing was initiated without a significant decline in the level of bioactive TNF-alpha. TNF-alpha-mediated events may not be the key events contributing to the impaired healing seen in chronic venous ulcers.
引用
收藏
页码:292 / 296
页数:5
相关论文
共 36 条
  • [1] ABRAMOWITZ HB, 1979, SURGERY, V86, P434
  • [2] STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS
    ADERKA, D
    ENGELMANN, H
    MAOR, Y
    BRAKEBUSCH, C
    WALLACH, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 323 - 329
  • [3] SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND SOLUBLE TNF RECEPTORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATIONS TO CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL PARAMETERS
    AUKRUST, P
    LIABAKK, NB
    MULLER, F
    LIEN, E
    ESPEVIK, T
    FROLAND, SS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) : 420 - 424
  • [4] BALIN AK, 1984, J EXP MED, V160, P152, DOI 10.1084/jem.160.1.152
  • [5] Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP
    Black, RA
    Durie, FH
    OttenEvans, C
    Miller, R
    Slack, JL
    Lynch, DH
    Castner, B
    Mohler, KM
    Gerhart, M
    Johnson, RS
    Itoh, Y
    Okada, Y
    Nagase, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (02) : 400 - 405
  • [6] CYTOPLASMIC TRUNCATION OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR ABOLISHES SIGNALING, BUT NOT INDUCED SHEDDING OF THE RECEPTOR
    BRAKEBUSCH, C
    NOPHAR, Y
    KEMPER, O
    ENGELMANN, H
    WALLACH, D
    [J]. EMBO JOURNAL, 1992, 11 (03) : 943 - 950
  • [7] CROWE PD, 1993, J IMMUNOL, V151, P6882
  • [8] TUMOR NECROSIS FACTOR-ALPHA INHIBITS CELL-PROLIFERATION AND INDUCES CLASS-II ANTIGENS AND CELL-ADHESION MOLECULES IN CULTURED NORMAL HUMAN KERATINOCYTES INVITRO
    DETMAR, M
    ORFANOS, CE
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1990, 282 (04) : 238 - 245
  • [9] HETEROGENEITY IN OXYGEN DIFFUSION AROUND VENOUS ULCERS
    FALANGA, V
    MCKENZIE, A
    EAGLSTEIN, WH
    [J]. JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1991, 17 (04): : 336 - 339
  • [10] TUMOR-NECROSIS-FACTOR TYPE-ALPHA, A POTENT INHIBITOR OF ENDOTHELIAL-CELL GROWTH-INVITRO, IS ANGIOGENIC INVIVO
    FRATERSCHRODER, M
    RISAU, W
    HALLMANN, R
    GAUTSCHI, P
    BOHLEN, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (15) : 5277 - 5281